GENETRON HOLDINGS LIMITED

(GTH)
  Report
Delayed Nasdaq  -  05/24 04:00:00 pm EDT
1.370 USD   -4.86%
05/23Genetron Health to Announce First Quarter 2022 Unaudited Financial Results and Host Investor Call on June 2, 2022
GL
05/23Genetron Health to Announce First Quarter 2022 Unaudited Financial Results and Host Investor Call on June 2, 2022
GL
04/21BTIG Adjusts Genetron Holdings' Price Target to $10 From $17, Keeps Buy Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Genetron Holdings Limited Reiterates Full Year 2021 Revenue Guidance

01/10/2022 | 06:00am EDT

Genetron Holdings Limited reiterated its full year 2021 revenue guidance. The Company expects full year 2021 revenue to be around RMB 530 million, representing approximately 25% growth over the Company’s full year 2020 revenue.


© S&P Capital IQ 2022
All news about GENETRON HOLDINGS LIMITED
05/23Genetron Health to Announce First Quarter 2022 Unaudited Financial Results and Host Inv..
GL
05/23Genetron Health to Announce First Quarter 2022 Unaudited Financial Results and Host Inv..
GL
04/21BTIG Adjusts Genetron Holdings' Price Target to $10 From $17, Keeps Buy Rating
MT
04/19Genetron Obtains CE Mark for Human B Lymphocyte Minimal Residual Disease Detection Kit
MT
04/19Genetron Health Receives CE Mark for Human B Lymphocyte Minimal Residual Disease Detect..
AQ
04/08Genetron Health Presents 17 New Research Results at American Association for Cancer Res..
GL
04/07Publication in Clinical and Translational Medicine Demonstrates Mutation Capsule™..
GL
04/07Publication in Clinical and Translational Medicine Demonstrates Mutation Capsule™..
GL
03/29TRANSCRIPT : Genetron Holdings Limited, Q4 2021 Earnings Call, Mar 29, 2022
CI
03/29GENETRON : Health Announces Unaudited Fourth Quarter and Full Year 2021 Financial Results ..
PU
More news
Analyst Recommendations on GENETRON HOLDINGS LIMITED
More recommendations
Financials (USD)
Sales 2022 97,3 M - -
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 -10,1x
Yield 2022 -
Capitalization 124 M 124 M -
Capi. / Sales 2022 1,28x
Capi. / Sales 2023 0,98x
Nbr of Employees 1 154
Free-Float 91,0%
Chart GENETRON HOLDINGS LIMITED
Duration : Period :
Genetron Holdings Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENETRON HOLDINGS LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 1,37 $
Average target price 4,76 $
Spread / Average Target 247%
EPS Revisions
Managers and Directors
Si Zhen Wang Chairman & Chief Executive Officer
Ce Xu Chief Financial Officer
Hai Yan Director & Chief Scientific Officer
Yu Chen Jiao Chief Technology Officer & Director
Yun Fu Hu Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
GENETRON HOLDINGS LIMITED-77.54%124
MODERNA, INC.-48.00%52 528
LONZA GROUP AG-27.13%42 896
IQVIA HOLDINGS INC.-28.41%38 232
SEAGEN INC.-13.67%24 569
ICON PUBLIC LIMITED COMPANY-30.17%17 581